Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization- Cost Effectiveness Study In Portugal
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.552
https://www.valueinhealthjournal.com/article/S1098-3015(15)02628-5/fulltext
Title :
Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization- Cost Effectiveness Study In Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02628-5&doi=10.1016/j.jval.2015.09.552
First page :
A420
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
471